Orum Therapeutics Statistics

Total Valuation

KOSDAQ:475830 has a market cap or net worth of KRW 1.74 trillion. The enterprise value is 1.62 trillion.

Market Cap	1.74T
Enterprise Value	1.62T

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:475830 has 21.16 million shares outstanding. The number of shares has decreased by -79.35% in one year.

Current Share Class	21.16M
Shares Outstanding	21.16M
Shares Change (YoY)	-79.35%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	16.46%
Owned by Institutions (%)	19.92%
Float	15.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	68,253.61
PB Ratio	11.98
P/TBV Ratio	11.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-43.94
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-45.90

Financial Position

The company has a current ratio of 10.32, with a Debt / Equity ratio of 0.17.

Current Ratio	10.32
Quick Ratio	9.92
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-0.71
Interest Coverage	-21.90

Financial Efficiency

Return on equity (ROE) is -26.73% and return on invested capital (ROIC) is -15.84%.

Return on Equity (ROE)	-26.73%
Return on Assets (ROA)	-15.12%
Return on Invested Capital (ROIC)	-15.84%
Return on Capital Employed (ROCE)	-24.67%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	21
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, KOSDAQ:475830 has paid 575.43 million in taxes.

Income Tax	575.43M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	46,871.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	81.51
Average Volume (20 Days)	393,170

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:475830 had revenue of KRW 25.48 million and -36.88 billion in losses. Loss per share was -2,048.72.

Revenue	25.48M
Gross Profit	25.22M
Operating Income	-41.41B
Pretax Income	-36.31B
Net Income	-36.88B
EBITDA	-38.34B
EBIT	-41.41B
Loss Per Share	-2,048.72

Full Income Statement

Balance Sheet

The company has 143.66 billion in cash and 25.12 billion in debt, giving a net cash position of 118.55 billion or 5,602.77 per share.

Cash & Cash Equivalents	143.66B
Total Debt	25.12B
Net Cash	118.55B
Net Cash Per Share	5,602.77
Equity (Book Value)	145.18B
Book Value Per Share	6,885.97
Working Capital	135.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -34.38 billion and capital expenditures -924.61 million, giving a free cash flow of -35.31 billion.

Operating Cash Flow	-34.38B
Capital Expenditures	-924.61M
Free Cash Flow	-35.31B
FCF Per Share	-1,668.63

Full Cash Flow Statement

Margins

Gross Margin	98.99%
Operating Margin	-162,507.51%
Pretax Margin	-142,478.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:475830 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	79.35%
Shareholder Yield	79.35%
Earnings Yield	-2.12%
FCF Yield	-2.03%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:475830 has an Altman Z-Score of 8.78 and a Piotroski F-Score of 1.

Altman Z-Score	8.78
Piotroski F-Score	1